Cure.

Cure CEO Seema Kumar asks famed Professor of Genetics George Church, PhD, at Harvard Medical School and Massachusetts Institute of Technology, during a Tuesday Talks with The New York Academy of Sciences, what gives us reason to believe and hope that AI-driven drug discovery will lead us to faster treatments and hopefully cures one day. #aiforgood #drugdiscovery

Luis Peña, President and CEO of Evommune, a Cure resident company, shares his top five tips for entrepreneurs based on his valuable lessons in leadership and management he has garnered from his extensive career in the life science industry. #entrepreneuriship #lifesciences #ceoadvice Check it out! https://lnkd.in/eEMdw-Nq

Exciting advancements in women's health! Evvy, a NYC startup, is making strides in understanding the vaginal microbiome to improve diagnostics and overall women's health. Pita Navarro, co-founder and CSO, sheds light on the potential of leveraging genomic sequencing of the vaginal microbiome to provide important insights into women's urinary and #reproductivehealth. #WomensHealth #Biotechnology #GenomicSequencing https://lnkd.in/e4GUvRZD

The FDA has released long-anticipated guidelines for improving diversity in clinical trials, and some experts in the biopharma industry are praising its arrival. Learn more about how manufacturers now need to format and implement “diversity action plans” for clinical trial enrollment. #FDA #clinicaltrials #diversityaction #biopharma https://lnkd.in/eMqFGD2H

AI can revolutionize medicine by enhancing drug development efficiency, accuracy and cost-effectiveness. Cure and The New York Academy of Sciences with Nicholas Dirks bring you a very special episode of Tuesday Talks with Seema Kumar with a panel of experts including George Church of Harvard Medical School, Maria Luisa Pineda, PhD. of Envisagenics, Grant W Mitchell, MD, MBA, of Every Cure and Thomas Fuchs of Icahn School of Medicine at Mount Sinai who will discuss AI's transformative role in bringing patients more effective treatments faster. #aiforgood #wewillcure

AI can revolutionize medicine by enhancing drug development efficiency, accuracy and cost-effectiveness. Cure and The New York Academy of Sciences with Nicholas Dirks bring you a very special episode of Tuesday talks with a panel of experts including George Church of Harvard University, Maria Luisa Pineda, PhD. of Envisagenics Grant W Mitchell, MD, MBA, of Every Cure and Thomas Fuchs of Icahn School of Medicine at Mount Sinai who will discuss AI's transformative role in bringing patients more effective treatments faster. #aiforgood #wewillcure

Brilliance can be found everywhere, but not everyone has the same opportunities. That's why a NYC non-profit organization Mentoring in Medicine, founded by Lynne Holden, MD and Andrew Morrison is dedicated to empowering students from elementary school through professional programs to pursue careers in healthcare. Learn more about their programs and the skills they taught to 80,000 students. https://lnkd.in/eZfrb_uW

In case you missed it, watch Darshak Sanghavi MD, a Program Managers at the Advanced Research Projects Agency for Health (ARPA-H) Sanghavi, who is a best-selling author, TED speaker and former CMO of United Healthcare, discusses the current and future state of health outcomes in the US and why prevention health care doesn’t work for most in the US. #wewillcure #futureofhealth

A conversation with CEO Mary Stutts, MHA, of the Healthcare Businesswomen’s Association, on the power of investing in women's healthcare and achieving gender parity in leadership. #wewillcure #investinginwomen #hbaimpact https://lnkd.in/ebS_Ah9h

In order to deliver equitable, accessible and transformative care for all, Cure partnered each Xchange Challenge winner with advisors who can help accelerate their AI solutions. Peter Njongwe, founder and CEO of Oben Health discusses how he is working with mentor and advisor John Mattison a leader in digital health. #aiforgood #wewillcure